Matches in SemOpenAlex for { <https://semopenalex.org/work/W2900936812> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W2900936812 abstract "To report outcomes from high-dose chemotherapy (HDCT) and autologous stem-cell transplantation (ASCT) for metastatic germ-cell cancer in Scotland.All patients who underwent this treatment between the years 2001 and 2016 at the Beatson West of Scotland Cancer Centre in Glasgow were identified. Information regarding baseline patient and tumor characteristics, prognostic features, HDCT delivery, and survival outcomes were obtained retrospectively from patients' medical records.Eighteen patients (15 male and 3 female subjects) received HDCT and ASCT in the salvage setting. Of the 14 male patients who had relapsed disease, 8 (57%) were high or very high risk according to the International Prognostic Factor Study Group (IPFSG) risk categorization. The mean time interval between HDCT cycles was 8.6 weeks, which is longer than the specified 3 to 4 weeks in the literature. A total of 67% of patients had no biochemical or radiologic evidence of disease after salvage treatment, including surgery. Progression-free survival and overall survival rates at 2 years were 67% and 72%, respectively. However, 12 patients (67%) and 6 patients (39%) had long-term neurotoxicity and ototoxicity, respectively.Delivery of HDCT and ASCT as salvage treatment for metastatic germ-cell cancer is feasible within a tertiary cancer center with survival outcomes comparable to published literature, although maintaining dose intensity is a challenge. We hope to recruit subjects to the international TIGER trial (ClinicalTrials.gov, NCT02375204), which will attempt to clarify if HDCT is superior to conventional-dose chemotherapy in the salvage setting." @default.
- W2900936812 created "2018-11-29" @default.
- W2900936812 creator A5020972434 @default.
- W2900936812 creator A5030221032 @default.
- W2900936812 creator A5031656031 @default.
- W2900936812 creator A5045828108 @default.
- W2900936812 creator A5046905571 @default.
- W2900936812 creator A5056414663 @default.
- W2900936812 creator A5072267975 @default.
- W2900936812 creator A5082554609 @default.
- W2900936812 date "2019-04-01" @default.
- W2900936812 modified "2023-09-27" @default.
- W2900936812 title "High-Dose Chemotherapy in Relapsed or Refractory Metastatic Germ-Cell Cancer: The Scotland Experience" @default.
- W2900936812 cites W2024854229 @default.
- W2900936812 cites W2034908295 @default.
- W2900936812 cites W2042770658 @default.
- W2900936812 cites W205553958 @default.
- W2900936812 cites W2069174619 @default.
- W2900936812 cites W2128723228 @default.
- W2900936812 cites W2158112007 @default.
- W2900936812 cites W2160492795 @default.
- W2900936812 cites W2163130660 @default.
- W2900936812 cites W2168588194 @default.
- W2900936812 cites W2187655448 @default.
- W2900936812 cites W2886615577 @default.
- W2900936812 cites W2907176272 @default.
- W2900936812 cites W44254208 @default.
- W2900936812 doi "https://doi.org/10.1016/j.clgc.2018.11.013" @default.
- W2900936812 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30563754" @default.
- W2900936812 hasPublicationYear "2019" @default.
- W2900936812 type Work @default.
- W2900936812 sameAs 2900936812 @default.
- W2900936812 citedByCount "2" @default.
- W2900936812 countsByYear W29009368122019 @default.
- W2900936812 countsByYear W29009368122020 @default.
- W2900936812 crossrefType "journal-article" @default.
- W2900936812 hasAuthorship W2900936812A5020972434 @default.
- W2900936812 hasAuthorship W2900936812A5030221032 @default.
- W2900936812 hasAuthorship W2900936812A5031656031 @default.
- W2900936812 hasAuthorship W2900936812A5045828108 @default.
- W2900936812 hasAuthorship W2900936812A5046905571 @default.
- W2900936812 hasAuthorship W2900936812A5056414663 @default.
- W2900936812 hasAuthorship W2900936812A5072267975 @default.
- W2900936812 hasAuthorship W2900936812A5082554609 @default.
- W2900936812 hasConcept C121608353 @default.
- W2900936812 hasConcept C126322002 @default.
- W2900936812 hasConcept C141071460 @default.
- W2900936812 hasConcept C143998085 @default.
- W2900936812 hasConcept C2776694085 @default.
- W2900936812 hasConcept C2776938808 @default.
- W2900936812 hasConcept C2780775027 @default.
- W2900936812 hasConcept C71924100 @default.
- W2900936812 hasConceptScore W2900936812C121608353 @default.
- W2900936812 hasConceptScore W2900936812C126322002 @default.
- W2900936812 hasConceptScore W2900936812C141071460 @default.
- W2900936812 hasConceptScore W2900936812C143998085 @default.
- W2900936812 hasConceptScore W2900936812C2776694085 @default.
- W2900936812 hasConceptScore W2900936812C2776938808 @default.
- W2900936812 hasConceptScore W2900936812C2780775027 @default.
- W2900936812 hasConceptScore W2900936812C71924100 @default.
- W2900936812 hasLocation W29009368121 @default.
- W2900936812 hasLocation W29009368122 @default.
- W2900936812 hasOpenAccess W2900936812 @default.
- W2900936812 hasPrimaryLocation W29009368121 @default.
- W2900936812 hasRelatedWork W2003306594 @default.
- W2900936812 hasRelatedWork W2032082494 @default.
- W2900936812 hasRelatedWork W2047214651 @default.
- W2900936812 hasRelatedWork W2105293222 @default.
- W2900936812 hasRelatedWork W2124197615 @default.
- W2900936812 hasRelatedWork W2389581939 @default.
- W2900936812 hasRelatedWork W2406687475 @default.
- W2900936812 hasRelatedWork W2557241190 @default.
- W2900936812 hasRelatedWork W2600735778 @default.
- W2900936812 hasRelatedWork W2791928451 @default.
- W2900936812 isParatext "false" @default.
- W2900936812 isRetracted "false" @default.
- W2900936812 magId "2900936812" @default.
- W2900936812 workType "article" @default.